CONNETICS CORP
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: CONNETICS CORP, 10-Q, 2000-11-14
Next: COTELLIGENT INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BALANCE
SHEET AND INCOME STATEMENT AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
10-Q.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          21,539
<SECURITIES>                                    74,136
<RECEIVABLES>                                    2,331
<ALLOWANCES>                                       100
<INVENTORY>                                        397
<CURRENT-ASSETS>                                97,881
<PP&E>                                           5,035
<DEPRECIATION>                                   3,458
<TOTAL-ASSETS>                                  99,880
<CURRENT-LIABILITIES>                            8,927
<BONDS>                                            388
                                0
                                          0
<COMMON>                                       158,104
<OTHER-SE>                                    (67,539)
<TOTAL-LIABILITY-AND-EQUITY>                    99,880
<SALES>                                         15,118
<TOTAL-REVENUES>                                31,146
<CGS>                                            2,979
<TOTAL-COSTS>                                    2,979
<OTHER-EXPENSES>                                34,286
<LOSS-PROVISION>                                   100
<INTEREST-EXPENSE>                                 207
<INCOME-PRETAX>                                (4,314)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,314)
<EPS-BASIC>                                    (.15)
<EPS-DILUTED>                                    (.15)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission